Expert Opinion on Therapeutic Targets

期刊简介：The journal evaluates molecules, signalling pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and early preclinical studies. Articles should not include clinical information including specific drugs and clinical trials.The Editors welcome:Reviews covering novel disease targets at the molecular level and information on early preclinical studies and their implications for future drug development.Articles should not include clinical information including specific drugs and clinical trials.Original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugs.The audience consists of scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D.

【译文】该期刊评估分子、信号通路、受体和其他治疗靶点及其作为药物开发候选者的潜力。该期刊的文章侧重于分子层面和早期临床前研究。文章不应包含临床信息，包括特定药物和临床试验。编辑欢迎：涵盖分子水平新型疾病靶点和早期临床研究及其对未来药物开发影响的综述。文章不应包含临床信息，包括特定药物和临床试验。报道目标选择和验证研究以及调查和上市药物的基本作用机制研究的原创研究论文。读者包括制药行业的科学家、经理和决策者、分子医学领域的学术研究人员以及其他密切参与研发的人员。